Science Explorer Back to mapMap
Discussion
Researcher · SQZ Biotech (United States) · United States

Armon Sharei

Armon Sharei publishes mostly in Molecular Biology, Biomedical Engineering and Oncology, on topics such as CAR-T cell therapy research, RNA Interference and Gene Delivery and Microfluidic and Bio-sensing Technologies.

OpenAlex
World rank
#1,067,085
of 7,710,434 ranked researchers
Rank in United States
#346,291
of 1,627,098
Works
70
Citations
3k
Citations per work
42.5
h-index
17
i10-index 19Top 42% in Molecular Biology
Armon Sharei

What does Armon Sharei research?

Armon Sharei's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Engineering (21%), Medicine (20%).

Life Sciences: 32 works · 45.1% of their workBiochemistry, Genetics and Molecular Biology: 23 works · 32.3% of their workMolecular Biology: 15 works · 22.1% of their workBiotechnology: 4 works · 5.6% of their workGenetics: 3 works · 4.6% of their workImmunology and Microbiology: 9 works · 12.8% of their workImmunology: 9 works · 12.8% of their workPhysical Sciences: 15 works · 21.0% of their workEngineering: 15 works · 21.0% of their workBiomedical Engineering: 15 works · 21.0% of their workHealth Sciences: 14 works · 19.5% of their workMedicine: 14 works · 19.5% of their workOncology: 14 works · 19.5% of their workEverything else: 10 works · 14.4% of their workTHEIR WORKArmon Sharei70works
Life Sciences45%Physical Sciences21%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2332.3%
    2. Immunology and Microbiology912.8%
    1. Engineering1521.0%
    1. Medicine1419.5%
  4. Everything else1014.4%
  1. 1Molecular Biology22% of their works
  2. 2Biomedical Engineering21% of their works
  3. 3Oncology20% of their works
  4. 4Immunology13% of their works
  5. 5Biotechnology6% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe Armon Sharei's research?

The keywords of their largest research topics: Cancer Immunotherapy, Gene Therapy, CAR T Cells, Chimeric Antigen Receptor, RNA Interference, siRNA Delivery, Microfluidics and Particle Separation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Immunotherapy512 topics
  2. Gene Therapy353 topics
  3. CAR T Cells331 topic
  4. Chimeric Antigen Receptor331 topic
  5. RNA Interference211 topic
  6. siRNA Delivery211 topic
  7. Microfluidics191 topic
  8. Particle Separation191 topic
  9. Dendritic Cells181 topic
  10. Immunity181 topic
  11. Bioprinting131 topic
  12. Tissue Engineering131 topic
  13. Genome Engineering91 topic
  14. RNA-Guided91 topic
  15. AAV81 topic
  16. Viral Vectors81 topic
  17. Electroporation61 topic
  18. Irreversible Electroporation61 topic

Where does Armon Sharei work?

Armon Sharei's main affiliation in the publication record is SQZ Biotech (United States), United States.

How many publications and citations does Armon Sharei have?

OpenAlex counts 70 works and 2,977 citations for Armon Sharei, an h-index of 17, ranking #1,067,085 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Armon Sharei. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.